Elesta SpA Information

We raised the bar in minimally invasive interventional medicine. EchoLaser is our core product which uses 21G introducer needles and 0.3 mm fibers allowing a painless, outpatient approach for a number of applications which we brag to call “micro-invasive”. Our key therapy areas are urology and endocrinology, where we’re making a difference for many patients worldwide suffering from BPH, Prostate Cancer, Benign Thyroid Nodules, Papillary Thyroid Carcinoma. Our laser-ultrasound based technology is unique and offers substantial advantages vs all other ablation techniques. We want to play an important role in the new frontier of Precision Medicine, which is more than genomics and bespoke pharmacological treatment, but includes more accurate imaging and non surgical treatments (e.g. ablation).